News

Results from early-stage trial show that 80% of participants who received one of two HIV vaccine candidates produced antibodies against viral proteins.
CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, has announced the ...
Nanocarriers have emerged as powerful tools in cancer therapy, offering targeted, efficient, and minimally invasive treatment ...
CAMBRIDGE, Mass., July 31, 2025 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today reported financial ...
Total Revenue Growth of 20% to $63.2 Million, with MACI Revenue Growth of 21% to $53.5 Million Gross Margin Increased More than 400 Basis Points to 74% Adjusted EBITDA Growth of 112% to $13.4 Million ...
Researchers at Johns Hopkins Medicine say they unexpectedly found new information about a protein's special role in getting ...
The immune system senses damage to cell membranes caused by pore-forming proteins and mounts a response. The sneezing, itchy ...
Salt creeping, a phenomenon that occurs in both natural and industrial processes, describes the collection and migration of ...
To further reduce the size of electronic devices, while also improving their performance and energy efficiency, electronics ...
This study offers useful findings demonstrating the cartilage-protective effects of osteoactivin in inflammatory experimental models. The study provides compelling evidence that osteoactivin may serve ...
The viruses that kill bacteria may be our best bet against antibiotic resistance — if we can understand how they win.